These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2760010)

  • 1. Presence of 1-O-alk-1'-enyl-2-O-acetyl glycerophosphocholine (vinyl form of PAF) in perfused rat and guinea pig hearts.
    Nakayama R; Saito K
    J Biochem; 1989 Apr; 105(4):494-6. PubMed ID: 2760010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-O-hexadec-1'-enyl-2-acetyl-sn-glycero-3-phosphocholine and its biological activity.
    Nakayama R; Yasuda K; Satouchi K; Saito K
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1256-61. PubMed ID: 3355555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acyl and plasmalogen analogs of platelet activating factor--new lipid cellular bioregulators].
    Kulikov VI; Muzia GI
    Biokhimiia; 1992 Jun; 57(6):803-16. PubMed ID: 1420585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
    Fitzgerald MF; Moncada S; Parente L
    Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
    Piper PJ; Stewart AG
    Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the coronary vascular responses to platelet-activating factor in the isolated perfused heart.
    Hu WM; Choy PC; Man RY
    Lipids; 1991 Sep; 26(9):700-4. PubMed ID: 1762514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on cardiac function in perfused guinea-pig heart.
    Saeki S; Masugi F; Ogihara T; Otsuka A; Kumahara Y; Watanabe K; Tamura K; Akashi A; Kumagai A
    Life Sci; 1985 Jul; 37(4):325-9. PubMed ID: 4010479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific variations in the molecular heterogeneity of the platelet-activating factor.
    Ramesha CS; Pickett WC
    J Immunol; 1987 Mar; 138(5):1559-63. PubMed ID: 3100641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-NAME augments PAF-induced venoconstriction in isolated perfused livers of rat and guinea pig, but not mouse.
    Cui S; Shibamoto T; Zhao Z; Takano H; Kurata Y
    Prostaglandins Leukot Essent Fatty Acids; 2007 May; 76(5):277-83. PubMed ID: 17395449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The release of lyso-PAF from guinea-pig lungs.
    Parente L; Fitzgerald M; De Nucci G; Moncada S
    Eur J Pharmacol; 1985 Jun; 112(2):281-4. PubMed ID: 4029263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyl type platelet-activating factor in normal rat uterus determined by gas chromatography mass spectrometry.
    Yasuda K; Satouchi K; Nakayama R; Saito K
    Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):137-41. PubMed ID: 3242662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart.
    Abete P; Ferrara N; Leosco D; Caccese P; Landino P; Sederino S; Balbi R; Rengo F
    J Mol Cell Cardiol; 1992 Dec; 24(12):1399-407. PubMed ID: 1293314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.
    Grigoriadis G; Stewart AG
    Br J Pharmacol; 1991 Sep; 104(1):171-7. PubMed ID: 1664761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig.
    Flores NA; Sheridan DJ
    Br J Pharmacol; 1990 Nov; 101(3):734-8. PubMed ID: 2076489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
    Hu WM; Man RY
    Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    Ring PC; Seldon PM; Barnes PJ; Giembycz MA
    Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PAF-acether effects on isolated guinea pig hearts by zinc ions (Zn2+).
    Evangelou A; Kalfakakou V; Benveniste J; Arnoux B
    Biol Trace Elem Res; 1995 Oct; 50(1):43-55. PubMed ID: 8546883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
    Komuro Y; Imanishi N; Uchida M; Morooka S
    Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of platelet-activating factor in glomeruli and cultured glomerular mesangial cells.
    Schlondorff D; Goldwasser P; Neuwirth R; Satriano JA; Clay KL
    Am J Physiol; 1986 Jun; 250(6 Pt 2):F1123-7. PubMed ID: 3087218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry.
    Savu SR; Silvestro L; Sörgel F; Montrucchio G; Lupia E; Camussi G
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):35-45. PubMed ID: 8832423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.